Cocrystal Pharma, Inc. (COCP)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch COCP
See up to 3 months of COCP. The 7-day demo opens the 1M and 3M ranges and puts COCP on your watchlist.
Start 7-day demoLatest COCP insider trades
About Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. files with the SEC under CIK 0001412486 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
COCP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 85,000 | $80K |
COCP insider transactions (Form 4)
3630 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 10,000 | $0.98 footnote F1 | $10K | |
| ||||||
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 75,000 | $0.94 footnote F1 | $71K | |
| ||||||
| James Sapirstein - Officer | Grant or award | Stock Options (Right to Buy) | 235,000 | $0.00 | - | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 20,000 | $1.00 footnote F1 | $20K | |
| ||||||
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 50,000 | $0.95 footnote F1 | $47K | |
| ||||||
| Roger D. Kornberg - Director | Grant or award | Stock Options (Right to Buy) | 24,615 | $0.00 | - | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| Sam Lee - Officer | Grant or award | Stock Options (Right to Buy) | 49,229 | $0.00 | - | |
 Fred Hassan - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| James Joseph Martin - Officer | Grant or award | Stock Options (Right to Buy) | 49,229 | $0.00 | - | |
| Phillip Md Et Al Frost - Director | Grant or award | Stock Options (Right to Buy) | 24,615 | $0.00 | - | |
| Anthony J. Japour - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| Steven D. Rubin - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 50,000 | $0.95 | $47K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 20,000 | $0.97 footnote F1 | $19K | |
| ||||||
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 25,000 | $0.97 footnote F1 | $24K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 40,000 | $0.97 footnote F1 | $39K | |
| ||||||
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 1,500 | $1.00 | $2K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 2,500 | $0.99 | $2K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 20,000 | $0.94 footnote F1 | $19K | |
| ||||||
| James Joseph Martin - Officer | Grant or award | Common Stock | 3,598 | $1.39 | $5K | |
| James Joseph Martin - Officer | Grant or award | Warrants | 7,196 | $1.39 | $10K | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Common Stock | 20,000 | - footnote F1 | - | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Warrants | 40,000 | $1.39 | $56K | |
| ||||||
| Fred Hassan - Director | Grant or award | Common Stock | 359,713 | $1.39 | $500K | |
| Fred Hassan - Director | Grant or award | Warrants | 719,426 | $1.39 | $1.00M | |
| Phillip Md Et Al Frost - Director | Grant or award | Warrants | 719,426 | $1.39 | $1.00M | |
| Phillip Md Et Al Frost - Director | Grant or award | Common Stock | 359,713 | $1.39 | $500K | |
| Sam Lee - Officer | Grant or award | Common Stock | 40,000 | - | - | |
| Roger D. Kornberg - Director | Grant or award | Common Stock | 28,109 | - | - | |
| Phillip Md Et Al Frost - Director | Grant or award | Common Stock | 27,100 | - | - | |
| James Joseph Martin - Officer | Grant or award | Common Stock | 40,000 | - | - | |
| Anthony J. Japour - Director | Grant or award | Common Stock | 14,924 | - | - | |
| Steven D. Rubin - Director | Grant or award | Common Stock | 18,957 | - | - | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Common Stock | 8,067 | - | - | |
| Fred Hassan - Director | Grant or award | Common Stock | 8,067 | - | - | |
Item 7.01, 9.01
Item 5.02, 9.01
Item 7.01, 9.01
Item 1.01, 3.02, 7.01, 9.01
COCP insider trading FAQ
What is the latest insider trade for COCP?
Cocrystal Pharma, Inc. (COCP) had 2 insider filings in the last 90 days, with the most recent on 2026-08-06. The full record for COCP runs to 30 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying COCP stock?
2 insider purchases of COCP were filed in the last 90 days, totaling $80K.
How many insiders are selling COCP stock?
No insider sales of COCP were filed in the last 90 days.
Where can I see COCP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects COCP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Phillip Md Et Al Frost view on EDGAR
- - Phillip Md Et Al Frost view on EDGAR
- - James Sapirstein view on EDGAR
- - Phillip Md Et Al Frost view on EDGAR
- - Phillip Md Et Al Frost view on EDGAR
- - Roger D. Kornberg view on EDGAR
- - Richard C. Pfenniger Jr. view on EDGAR
- - Sam Lee view on EDGAR
- - Fred Hassan view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where COCP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow COCP with a 7-day demo
- COCP on your watchlist
- Every COCP Form 4 filing on record
- Up to 3 months of COCP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
